8-K//Current report
AN2 Therapeutics, Inc. 8-K
Accession 0001193125-25-143187
$ANTXCIK 0001880438operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 7:00 AM ET
Size
257.7 KB
Accession
0001193125-25-143187
Documents
- 8-Kd50241d8k.htmPrimary
8-K
- EX-4.1d50241dex41.htm
EX-4.1
- EX-101.SCHantx-20250617.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABantx-20250617_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREantx-20250617_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-143187-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd50241d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001880438
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 7:00 AM ET
- Size
- 257.7 KB